Thrivent Financial for Lutherans Boosts Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Thrivent Financial for Lutherans increased its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 12.9% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 19,181 shares of the medical instruments supplier’s stock after acquiring an additional 2,190 shares during the period. Thrivent Financial for Lutherans owned about 0.08% of ICU Medical worth $3,495,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in ICUI. Hexagon Capital Partners LLC raised its stake in shares of ICU Medical by 162.7% during the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 122 shares in the last quarter. Allworth Financial LP raised its position in ICU Medical by 100.0% in the 3rd quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 100 shares during the period. Innealta Capital LLC bought a new stake in ICU Medical in the second quarter worth $32,000. Venturi Wealth Management LLC boosted its position in ICU Medical by 1,510.0% during the third quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock valued at $59,000 after buying an additional 302 shares during the period. Finally, EntryPoint Capital LLC grew its stake in shares of ICU Medical by 731.5% during the first quarter. EntryPoint Capital LLC now owns 449 shares of the medical instruments supplier’s stock valued at $48,000 after buying an additional 395 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

Insider Buying and Selling

In related news, CEO Vivek Jain sold 12,000 shares of the company’s stock in a transaction on Friday, November 1st. The stock was sold at an average price of $171.84, for a total value of $2,062,080.00. Following the sale, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at $17,973,261.12. This represents a 10.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Daniel Woolson sold 2,502 shares of the firm’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $163.22, for a total value of $408,376.44. Following the transaction, the vice president now directly owns 13,107 shares of the company’s stock, valued at $2,139,324.54. This represents a 16.03 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 38,502 shares of company stock valued at $6,573,496 over the last three months. Corporate insiders own 6.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on ICUI. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. Raymond James increased their price objective on ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a research note on Thursday, September 12th. StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Jefferies Financial Group assumed coverage on shares of ICU Medical in a research report on Monday, October 14th. They set a “hold” rating and a $183.00 price target for the company. Finally, KeyCorp boosted their price objective on shares of ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research report on Wednesday, November 13th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $173.00.

ICU Medical Stock Down 0.4 %

Shares of NASDAQ ICUI opened at $167.81 on Tuesday. The firm has a fifty day simple moving average of $175.98 and a two-hundred day simple moving average of $146.15. ICU Medical, Inc. has a 12 month low of $83.26 and a 12 month high of $196.26. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The firm has a market capitalization of $4.11 billion, a PE ratio of -36.72 and a beta of 0.66.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.